- Fund Type: ETF
- Objective: Health Care
- Asset Class: Equity
- Geographic Focus: U.S.
iShares U.S. Healthcare ETF
+ Add to WatchlistIYH:US
107.3310 USD 0.8890 0.82%As of 13:25:01 ET on 10/03/2013.
Snapshot for iShares U.S. Healthcare ETF (IYH)
| Open: | 107.8600 | High - Low: | 107.9200 - 106.7700 | Primary Exchange: | NYSE Arca |
|---|---|---|---|---|---|
| Volume: | 48,868 | 52-Week Range: | 80.3200 - 110.1500 | Beta vs DJUSHC: | 0.9905 |
Fund Profile & Information for IYH
iShares U.S. Healthcare ETF is an exchange-traded fund incorporated in the USA. The Fund's objective seeks investment results that correspond to the performance of the Dow Jones U.S. Healthcare Sector Index. The Fund will concentrate its investments in the healthcare sector to approximately the same extent the Index is so concentrated.
| Inception Date: | 2000-06-16 | Telephone: | 1-415-670-2000 |
|---|---|---|---|
| Managers: | GREG SAVAGE | ||
| Web Site: | www.ishares.com | ||
Fundamentals for IYH
| NAV | (on 2013-10-02) 108.1700 |
|---|---|
| Assets (M) | (on 2013-10-02) 1,725.3040 |
| Shares out (M) | 15.95 |
| Market Cap (M) | 1,710.48 |
| % Premium | 0.05 |
| Average 52-Week % Premium | 0.0118 |
| Fund Leveraged | N |
Dividends for IYH
| Dividend Type | Income |
|---|---|
| Dividend Frequency | Quarter |
| Last Dividend Net | - |
| Dividend Yield (ttm) | 1.23% |
Performance for IYH
| 1-Month | +4.42% | 1-Year | +28.29% |
|---|---|---|---|
| 3-Month | +7.93% | 3-Year | +21.44% |
| Year To Date | +30.80% | 5-Year | +13.95% |
| Expense Ratio | 0.46 |
Top Fund Holdings for IYH
Filing Date: 10/01/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Johnson & Johnson | 2,316,860 | 202,655,744 | 11.622% |
| Pfizer Inc | 5,442,831 | 157,243,388 | 9.017% |
| Merck & Co Inc | 2,405,899 | 117,263,517 | 6.725% |
| Gilead Sciences Inc | 1,258,393 | 79,027,080 | 4.532% |
| Amgen Inc | 619,366 | 70,966,956 | 4.070% |
| Bristol-Myers Squibb Co | 1,353,513 | 63,939,954 | 3.667% |
| UnitedHealth Group Inc | 835,872 | 60,667,590 | 3.479% |
| AbbVie Inc | 1,303,448 | 59,697,918 | 3.424% |
| Celgene Corp | 338,127 | 53,153,564 | 3.048% |
| Biogen Idec Inc | 195,401 | 47,857,613 | 2.745% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page